Parallel Biosystems

BiotechnologySeries ACambridge, USparallel.bio

Latest round

Series A

Last raised

Jun 2025

Total raised

$25M

Investors

9

About Parallel Biosystems

Based in Massachusetts, US, and founded in 2021 by its CEO Robert M. DiFazio, and CSO Juliana L. Hilliard, Parallel Biosystems, Inc. operates as a biotech company that develops replicates of the human immune system in a dish for drug discovery and development. In June 2025, Parallel Biosystems, Inc. Parallel Biosystems, Inc. develops a platform that combines human immune organoids with artificial intelligence and robotics to analyze the hundreds of cells and thousands of molecules that comprise the immune system and generate unprecedented insights into human health and disease. The immune organoid, which is a mini human lymph node, each organoid is about the size of a pencil eraser and has all the same molecules, cells, and structures found in human lymph nodes.

Who invested in Parallel Biosystems

9 investors across 2 rounds

See all investors in Parallel Biosystems

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 12, 2025

    Amount

    $21M

    Investors

    Locked

  2. Seed

    Dec 20, 2022

    Amount

    $4.3M

    Investors

    Locked

Questions about Parallel Biosystems

Who invested in Parallel Biosystems?

Parallel Biosystems has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Parallel Biosystems raised?

Parallel Biosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Parallel Biosystems last raise money?

Parallel Biosystems's most recent round on record is a Series A, in Jun 2025.

What does Parallel Biosystems do?

Based in Massachusetts, US, and founded in 2021 by its CEO Robert M.

Where is Parallel Biosystems headquartered?

Parallel Biosystems is headquartered in Cambridge, US.

Which VCs invest in companies like Parallel Biosystems?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Parallel Biosystems's stage. Their profiles are linked below.

Raising like Parallel Biosystems? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.